Alcon bought Aerie Pharmaceuticals Aerie Pharmaceuticals from 11/22/22

User image

Vladimir Petenev

News editor
press@blackterminal.com

Alcon completed its acquisition of Aerie Pharmaceuticals for $770 million, or 15.25 per share.

Aerie Pharmaceuticals

Review

Source:

{source} pictogram

investor.alcon.com

Vladimir Petenev

News editor

Write your comment first

News feed

Sollers in the 1st half of the year increased sales in Russia by 41.2%

7/2/24 SVAV

Fix Price opened its 300th store in Kazakhstan

7/2/24 FIXP

Moscow Exchange summarized the results of trading in June

7/2/24 MOEX

Shareholders of Kazanorgsintez approved dividends for 2023

7/2/24 KZOS

Shareholders of Nizhnekamskneftekhim approved dividends for 2023

7/2/24 NKNC

Shareholders of Lenzoloto approved dividends for 2023

7/2/24 LNZL

Gazprom Neft estimated the share of hard-to-recover reserves in production

7/2/24 SIBN

Segezha plans to export to Asia 60 thousand cubic meters of products

7/2/24 SGZH

Seligdar discovered the Ryabchik deposit

7/2/24 SELG

Shareholders of Abrau-Durso approved dividends for 2023

7/2/24 ABRD